Alnylam Pharmaceuticals reported $1.07B in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US USD 154.84M 15.01M
Agios Pharmaceuticals AGIO:US USD 122.45M 33.91M
Alnylam Pharmaceuticals ALNY:US USD 1.07B 497.67M
Amgen AMGN:US USD 9.3B 197M
Avrobio Inc AVRO:US USD 115.97M 16.44M
Biocryst Pharmaceuticals BCRX:US USD 461.19M 43.71M
Biomarin Pharmaceutical BMRN:US USD 761.52M 141.71M
Bluebird Bio BLUE:US USD 66.48M 15.02M
Intercept Pharmaceuticals ICPT:US USD 113.2M 55.18M
IONIS PHARMACEUT IONS:US USD 314.99M 206.92M
Mirati Therapeutics MRTX:US USD 173.53M 71.97M
Moderna Inc MRNA:US USD 3.03B 154M
Novartis NVS:US USD 7.52B 1.21B
Ptc Therapeutics PTCT:US USD 104.42M 53.73M
Regeneron Pharmaceuticals REGN:US USD 14.33B 10.84B
Regulus Therapeutics RGLS:US USD 20.01M 15.1M
Sangamo Biosciences SGMO:US USD 94.57M 23.14M
Sarepta Therapeutics SRPT:US USD 1.04B 170.06M
Takeda 4502:JP JPY 685.14B 113B
Ultragenyx Pharmaceutical RARE:US USD 391.65M 231.78M
Vertex Pharmaceuticals VRTX:US USD 9.17B 469.3M
Xencor XNCR:US USD 52.65M 3.24M
YTE INCY:US USD 2.69B 255.24M